bioRxivBioengineeringPreprint
Ultrasound Activated Nanobubbles Induce Durable Systemic Antitumor Immunity
Anubhuti Bhalotia, Pinunta NittayacharniD, Diarmuid W. Hutchinson, Andrew Cheplyansky, Kayo Takizawa, Abraham Nidhiry, S. I. HariharaniD, Ashley Novak, Arya Iyer, Meghna MehtaiD, Theresa KosmidesiD, Reshani PereraiD, Inga M. Hwang, Agata A. ExneriD, Efstathios KarathanasisiD
Abstract
Clinical outcomes in aggressive breast cancer vary widely, in part because the tumor microenvironment is structured to exclude immune infiltration. Low antigen load, dysfunctional antigen-presenting cells, T cell exclusion and exhaustion, and a stiff extracellular matrix that physically restricts immune cell trafficking work together to form a suppressive barrier that current immunotherapies struggle to overcome. We addressed this barrier using ultrasound (US)-activated nanobubbles (NBs), a drug-free intervention based on perfluoropropane-filled nanoparticles. The size and deformable phospholipid shell enable NBs to achieve deep tumor penetration and a uniform distribution throughout the entire tumor. Upon ultrasound activation, NBs generate localized mechanical forces that restore extracellular matrix elasticity, disrupt tumor transport barriers, and drive HMGB1 release, re-engaging endogenous antitumor immunity without pharmacological agents. In a syngeneic triple-negative breast cancer model, US-NB treatment depleted immunosuppressive myeloid cells 3-fold within 3 hours, followed by a greater than 5-fold increase in the ratio of antigen-experienced to suppressive T cells at 48 hours. US-NB drives rapid infiltration of CD4+ and CD8+ T cells within 48 hours. US-NB treatment achieved an 85% cure rate in the D2A1 model; cured animals maintained durable systemic immune memory, rejecting both local and systemic tumor rechallenge. Consistent therapeutic benefit was observed in a luminal B-like mammary tumor model (E0771), supporting activity across breast cancer subtypes. These results establish US-NB mechanical immunomodulation as a drug-free therapeutic strategy capable of generating robust and durable antitumor immunity, acting through biophysical tissue properties rather than tumor-specific molecular targets. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=90 SRC="FIGDIR/small/714247v1_ufig1.gif" ALT="Figure 1"> View larger version (56K): org.highwire.dtl.DTLVardef@8f274eorg.highwire.dtl.DTLVardef@5da575org.highwire.dtl.DTLVardef@19defborg.highwire.dtl.DTLVardef@7e630e_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: mouse
- research focus: host-pathogen & immune response
- research focus: cancer & tumor microenvironment
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systemic Nanobubbles Enable Ultrasound-Guided STING Immunotherapy in Breast Cancer
Nazia Hafeez, Sina Khorsandi, … Jacques Lux·bioRxiv·Aug 19, 2026
- Enhanced delivery of lipid nanoparticle-based immunotherapy by modulating the tumor tissue stiffness using ultrasound-activated nanobubbles
Anubhuti Bhalotia, Diarmuid W. Hutchinson, … Efstathios Karathanasis·ACS NanoPeer-reviewed·Jan 28, 2026
- Focused Ultrasound Thermal Ablation and CD40 Agonism Reprograms Breast Tumor Immunity to Drive Regression and Memory
Zehra E.F. Demir, AeRyon Kim, … Natasha Sheybani·Journal for ImmunoTherapy of CancerPeer-reviewed·Aug 1, 2026
- Ultrasound-Mediated Drug-free Theranostics for Treatment of Prostate Cancer
R. H. Perera, F. M. Berg, … A. A. Exner·Bioactive MaterialsPeer-reviewed·May 1, 2024
- Laser nanobubbles induce immunogenic cell death in breast cancer
H. T. M. Nguyen, N. Katta, … J. W. Tunnell·bioRxiv·Sep 4, 2020
- Simulation-guided non-thermal low-intensity ultrasound reprograms the tumor immune microenvironment and engages systemic antitumor immunity in a syngeneic orthotopic mouse model of breast cancer
Reyhaneh Hooshmandabbasi, Ali Kazemian, … Caroline Maake·bioRxiv·Aug 18, 2026